NEO (STOCKS)
NeoGenomics, Inc.
$8.238000
+0.238000 (+2.97%)
Prev close: $8.000000
Company Information
- Exchange
- XNAS
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- CEO
- Anthony P. Zook
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,084.58M
- Employees
- 2,200
- P/E (TTM)
- -9.89
- P/B (TTM)
- 1.23
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $727.33M |
| Benefits Costs and Expenses | $837.60M |
| Cost Of Revenue | $413.04M |
| Costs And Expenses | $837.60M |
| Gross Profit | $314.29M |
| Operating Expenses | $430.17M |
| Research and Development | $37.08M |
| Other Operating Expenses | $393.10M |
| Operating Income/Loss | -$115.88M |
| Income/Loss From Continuing Operations After Tax | -$108.03M |
| Income/Loss From Continuing Operations Before Tax | -$110.27M |
| Income Tax Expense/Benefit | -$2.24M |
| Income Tax Expense/Benefit, Current | $866.00K |
| Income Tax Expense/Benefit, Deferred | -$3.11M |
| Net Income/Loss | -$108.03M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$108.03M |
| Net Income/Loss Available To Common Stockholders, Basic | -$108.03M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Average Shares | 128,101,000 |
| Diluted Average Shares | 128,101,000 |
| Assets | $1.36B |
| Current Assets | $376.29M |
| Inventory | $28.57M |
| Prepaid Expenses | $21.44M |
| Other Current Assets | $326.28M |
| Noncurrent Assets | $983.54M |
| Fixed Assets | $84.83M |
| Intangible Assets | $286.53M |
| Other Non-current Assets | $612.18M |
| Liabilities | $523.27M |
| Current Liabilities | $88.30M |
| Accounts Payable | $23.09M |
| Wages | $47.58M |
| Other Current Liabilities | $17.63M |
| Noncurrent Liabilities | $434.97M |
| Long-term Debt | $341.86M |
| Other Non-current Liabilities | $93.11M |
| Equity | $836.56M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $836.56M |
| Liabilities And Equity | $1.36B |
| Net Cash Flow From Operating Activities | $5.23M |
| Net Cash Flow From Operating Activities, Continuing | $5.23M |
| Net Cash Flow From Investing Activities | -$12.34M |
| Net Cash Flow From Investing Activities, Continuing | -$12.34M |
| Net Cash Flow From Financing Activities | -$200.29M |
| Net Cash Flow From Financing Activities, Continuing | -$200.29M |
| Net Cash Flow | -$207.39M |
| Net Cash Flow, Continuing | -$207.39M |
| Comprehensive Income/Loss | -$107.82M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$107.82M |
| Other Comprehensive Income/Loss | -$107.82M |
| Other Comprehensive Income/Loss Attributable To Parent | $210.00K |